Haploidentical Hematopoietic Stem Cell Transplantation

Clinical trial NCT02165007 · COMPLETED

Trial details

NCT number: NCT02165007
Sponsor: Catherine Bollard
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell-thalassemia Disease Thalassemia

Start date: 2015-01-01
Primary completion: 2024-01-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.